Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Crisaborole vs Tacrolimus in Pediatric Atopic Dermatitis
NCT07162896Phase 3Not yet recruiting
- Sponsor
- Shalamar Institute of Health Sciences
- Start
- Jun 2026
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of crisaborole in atopic dermatitis (AD), sponsored by Shalamar Institute of Health Sciences. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
crisaborole
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT07162896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07162896.